These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3947106

  • 21. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ, Paik WH, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [Abstract] [Full Text] [Related]

  • 22. [Pharmacokinetics of epirubicin in cancer patients].
    Ohno T, Shimoyama T, Kimura K, Yamada H.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1881-6. PubMed ID: 3458430
    [Abstract] [Full Text] [Related]

  • 23. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H, Takahashi H, Miyamoto K, Uchida T, Tokiwa T.
    Cancer Chemother Pharmacol; 1996 May; 38(5):417-24. PubMed ID: 8765434
    [Abstract] [Full Text] [Related]

  • 24. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [Abstract] [Full Text] [Related]

  • 25. Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients.
    Martini A, Moro E, Pacciarini MA, Tamassia V, Natale N, Piazza E.
    Int J Clin Pharmacol Res; 1984 Apr; 4(3):231-8. PubMed ID: 6593309
    [Abstract] [Full Text] [Related]

  • 26. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K, Furuta I, Ota K.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [Abstract] [Full Text] [Related]

  • 27. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y, Kubota T, Kuo TH, Furukawa T, Kase S, Tanino H, Ishibiki K, Kitajima M, Hoffman RM.
    Anticancer Res; 1994 Apr; 14(2A):469-73. PubMed ID: 8017850
    [Abstract] [Full Text] [Related]

  • 28. [Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer].
    Robert J, David M, Huet S, Chauvergne J, Monnier A.
    Bull Cancer; 1989 Apr; 76(8):889-92. PubMed ID: 2620119
    [No Abstract] [Full Text] [Related]

  • 29. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer].
    Makimoto T, Hoshino H, Tsuchiya S, Nakano H, Watanabe S, Naruse I, Fueki N, Ezawa K, Takise A, Saitoh R.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells.
    Yamaue H, Tanimura H, Noguchi K, Shono Y, Iwahashi M, Hotta T, Tani M, Tsunoda T, Nishimoto N, Terasawa H, Nakamori M.
    Anticancer Res; 1996 Dec; 16(1):243-6. PubMed ID: 8615614
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues.
    Shinozawa S, Fukuda T, Araki Y, Oda T.
    Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
    Masuda H, Hirai M, Ohtawara Y, Tajima A, Aso Y.
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
    [Abstract] [Full Text] [Related]

  • 37. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000
    [Abstract] [Full Text] [Related]

  • 38. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS, Riggs CE, Bachur NR.
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.